• Mon, April 11, 2022
• Tue, April 12, 2022
Justin Kim Maintained (BCRX) at Buy with Decreased Target to $16 on, Apr 11th, 2022
Justin Kim of Oppenheimer, Maintained "BioCryst Pharmaceuticals, Inc." (BCRX) at Buy with Decreased Target from $20 to $16 on, Apr 11th, 2022.
Justin, nor any peers, have made any analyst calls on BCRX in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30Like: 👍
